{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Use of AI in drug discovery for contagious diseases without thorough validation and testing\",\"Impact\":\"Potential for ineffective or harmful drugs to enter the market\",\"Mitigation\":\"Thorough validation of AI-generated drug candidates through rigorous testing and clinical trials\",\"Technologies\":\"Clinical trial platforms, drug validation technologies\",\"People\":\"Patients, healthcare providers, pharmaceutical companies\",\"Owner\":\"Regulatory authorities, pharmaceutical companies, research institutions\"},{\"Description\":\"Repurposing existing drugs without sufficient evidence for effectiveness against COVID-19\",\"Impact\":\"Increased risk of using drugs that may not be effective against COVID-19\",\"Mitigation\":\"Conducting comprehensive studies and trials to validate the effectiveness of repurposed drugs\",\"Technologies\":\"Clinical trial platforms, drug validation technologies\",\"People\":\"Patients, healthcare providers, pharmaceutical companies\",\"Owner\":\"Regulatory authorities, pharmaceutical companies, research institutions\"},{\"Description\":\"Development of AI-created drugs without comprehensive understanding of potential side effects\",\"Impact\":\"Possibility of unforeseen side effects in AI-created drugs\",\"Mitigation\":\"Thorough analysis of potential side effects and long-term impact of AI-created drugs through extensive testing\",\"Technologies\":\"Drug safety testing platforms, pharmacovigilance technologies\",\"People\":\"Patients, healthcare providers, pharmaceutical companies\",\"Owner\":\"Regulatory authorities, pharmaceutical companies, research institutions\"}]}"}}